How to use Technology Searches
The `Technologies Searched´-section displays profiles of unmet needs covering a broad spectrum from scientific expertise to clinical stage product candidates. Text search allows the use of phrases not yet part of our category lists. Key words can be used in combination and help identifying the hits most relevant for you.
A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in `Sector´, "Cancerous, neoplasmatic" in `Disease Category, "Drugs, Small Molecule" in `Technology´ and "Preclinical" in `Development Stage. Selection of "Enabling Technology, Platform technology" in `Sector´ will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee. Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.
Summary
MGI is seeking opportunities in Supportive Care and oncology
Organization name
MGI Pharma business development
Profile
MGI PHARMA is an oncology and acute care focused biopharmaceutical company that acquires, develops and commercializes proprietary products that address the unmet needs of patients.
Their goal is to become a leader in oncology and acute care by focusing on their three core competencies of product acquisition, development and commercialization.
As a result, they acquire intellectual property or product rights from others after basic research and discovery have been completed.
MGI PHARMA's business development and licensing group focuses on identifying opportunities in the area of cancer therapeutics:
Small Molecules:
- Cytotoxics targeted agents
Biologics:
- Monoclonal antibodies
- Protein therapeutics
MGI PHARMA's business development and licensing group focuses on identifying opportunities in the area of Supportive Care:
- Nausea and vomiting
- Myelosuppression
- Mucositis and xerostomia
- Infection Fatigue
- Neuropathy
- other toxicities
URL
http://www.mgipharma.com/wt/page/strategic_alliancesYour feedback
back